/ Report Details / Gene Editing Market

Gene Editing Market, By Application (Cell Line Engineering, Animal Genetic Engineering, and Plant Genetic Engineering), By Technology, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Report Code: AV3706

Industry: Healthcare

Publiced On: 2025-04-08

Pages: 383

Format: ppt pdf

REPORT HIGHLIGHT

Gene Editing Market size was valued at US$ 4,767.12 Million in 2024, expanding at a CAGR of 10.5% from 2025 to 2032.

Gene editing is a targeted molecular technology that involves deliberately modifying an organism\'s DNA to insert, delete, or alter genetic material at specific sites within the genome. This precise approach enables scientists to make exact changes to the DNA sequence, proving invaluable in fields such as medicine, agriculture, and biotechnology. Unlike traditional genetic modification, which introduces foreign genes into an organism, gene editing focuses on altering the organism\'s native genetic code. Technologies like CRISPR/Cas9, TALENs (Transcription Activator-Like Effector Nucleases), and Zinc Finger Nucleases (ZFNs) have revolutionized gene editing, making it more accessible, precise, and cost-effective. These advancements have paved the way for groundbreaking applications, including treatments for genetic disorders, improved crop yields, and innovative therapies for previously untreatable diseases.

Gene Editing Market- Market Dynamics

The growing demand for genetic therapies and personalized medicine is a key driver of the gene editing market. Advances in CRISPR/Cas9 and other gene-editing technologies have significantly improved treatment precision, leading the healthcare sector to increasingly adopt gene editing for treating genetic disorders such as hemophilia, cystic fibrosis, and sickle cell anemia. According to the National Institutes of Health (NIH), over 5,000 genetic diseases are potentially treatable with gene therapy. Strong government support and funding, particularly in countries like the United States and China, have bolstered research and development in gene editing. In the U.S., the National Institute of General Medical Sciences allocated over $3.5 billion to genetic research in 2022, reflecting the growing focus on this area.

Furthermore, the expanding application of gene editing in agriculture, such as developing pest- and disease-resistant crops, is contributing to market growth. The technology also supports advancements in cell line and animal genetic engineering, enhancing disease modeling and the production of biopharmaceuticals. Additionally, gene editing holds substantial potential in regenerative medicine, with investments from both private and public sectors accelerating innovation and commercialization. However, challenges such as ethical concerns surrounding human germline editing, regulatory barriers, and the high costs and complexity of gene-editing technologies could restrain market growth.

Gene Editing Market- Segmentation Analysis:
The Global Gene Editing Market is segmented based on Application, Technology, End-User, and Region.

The gene editing market is categorized based on application, technology, and end-user sectors. In 2021, the cell line engineering segment accounted for over $2.2 billion, highlighting its pivotal role in drug discovery and vaccine development. The animal genetic engineering segment is experiencing rapid growth, propelled by innovations in gene-editing tools aimed at enhancing farm yields and disease resistance. According to Grand View Research, the global genome editing market size is expected to reach $25 billion by 2030, exhibiting a CAGR of 16.94% from 2024 to 2030.

Regarding technology, the CRISPR/Cas9 segment held the largest market share of 43.52% in 2023, attributed to its precision, efficiency, and cost-effectiveness. Zinc Finger Nucleases (ZFNs) are projected to witness a substantial CAGR of 16.56%, particularly in clinical applications targeting genetic disorders such as sickle cell anemia and hemophilia. In 2024, investment in gene therapy and gene-editing products declined to $1.4 billion across 39 venture rounds, down from $8.2 billion in 2021.

End-users in the gene editing market include biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations. Biotech and pharma companies held a market share of 50.95% in 2023, driven by a focus on developing new gene editing technologies. North America dominated the market with a 47.81% share in 2023, owing to significant investments in gene editing R&D and a high prevalence of rare diseases.

Gene Editing Market- Geographical Insights

North America holds the largest share in the gene editing market, fueled by significant investments in biotechnology, a robust research infrastructure, and supportive government policies. The United States leads in gene-editing research and development, with the Food and Drug Administration (FDA) actively endorsing gene therapy trials. In 2021, the U.S. government allocated over $6.5 billion to genetic research through the National Institutes of Health (NIH), underscoring its commitment to advancing gene-editing technologies. The region\'s growth is further supported by the presence of top biotech companies and research centers, alongside increasing demand for targeted medicine and rapid advancements in gene therapies.

Asia-Pacific is the fastest-growing region, primarily driven by substantial investments in biotechnology in China and Japan. Both countries are swiftly adopting advanced gene-editing technologies for medical and agricultural applications. In China, the government has made significant strides in biotechnology, with the Ministry of Science and Technology investing over $3.2 billion in genetic research initiatives in 2022. The rising demand for gene-modified crops and expanding interest in gene therapies are accelerating market growth, with China playing a pivotal role in research and clinical trials. The region’s potential for high growth rates is bolstered by government support and improvements in healthcare infrastructure.

Gene Editing Market- Competitive Landscape:

The gene editing market is highly competitive, with numerous leading players driving technological advancements globally. Key contributors include Horizon Discovery Ltd., Sangamo Therapeutics, Inc., GenScript, and Thermo Fisher Scientific Inc., all of which invest heavily in research and development (R&D) to enhance gene-editing tools, particularly focusing on CRISPR/Cas9 and emerging technologies. To maintain their competitive edge, these companies pursue strategic partnerships, collaborations, and the development of innovative gene-editing products. Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences, Inc. are also at the forefront, leading clinical trials aimed at gene therapies for genetic disorders, which are expected to shape the market\'s future. Market competition revolves around technological innovation, regulatory approvals, and clinical advancements, enabling industry leaders to dominate the evolving gene-editing landscape.

Recent Developments:

• January 2025: Beam Therapeutics launched the first clinical trial site for its Phase 1/2 study of BEAM-301, an in vivo base editor under development for the potential treatment of glycogen storage disease type 1a (GSD1a).

• December 2024: Beam Therapeutics presented initial data from its BEACON Phase 1/2 clinical trial of BEAM-101 for sickle cell disease at the American Society of Hematology (ASH) Annual Meeting.

• December 2024: Intellia Therapeutics dosed the first patient in its global Phase 3 HAELO study evaluating NTLA-2002 for hereditary angioedema (HAE).

• March 2024: GenScript partnered with PersonGen-Anke Cellular Therapeutics to advance cell isolation products, enhancing cell therapy development and production efficiency.

• February 2024: CRISPR Therapeutics reported promising Phase 1 clinical trial results for CTX310, an in vivo gene-editing therapy targeting ANGPTL3, aimed at treating hypercholesterolemia and hypertriglyceridemia.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE EDITING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Horizon Discovery Ltd.
Ø Sangamo Therapeutics, Inc.
Ø GenScript
Ø Integrated DNA Technologies, Inc.
Ø Precision Biosciences
Ø Bearn Therapeutics
Ø Thermo Fisher Scientific Inc.
Ø Intellia Therapeutics, Inc.
Ø CRISPR Therapeutics
Ø Caribou Biosciences, Inc.

GLOBAL GENE EDITING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Cell Line Engineering
Ø Animal Genetic Engineering
Ø Plant Genetic Engineering
Ø Others

GLOBAL GENE EDITING MARKET, BY TECHOLOGY- MARKET ANALYSIS, 2019 - 2032
Ø CRISPR/Cas9
Ø Zinc Finger Nucleases (ZFNs)
Ø TALENs
Ø Others

GLOBAL GENE EDITING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Ø Biotech And Pharma Companies
Ø Contract Research Organizations (CROs)
Ø Research Institutes

GLOBAL GENE EDITING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o U.S.
o Canada
Ø Europe
o Germany
o UK
o France
o Italy
o Spain
o The Netherlands
o Sweden
o Russia
o Poland
o Rest of Europe
Ø Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
o Thailand
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA

TABLE OF CONTENT

1. Gene Editing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Gene Editing Market Snippet By Application
2.1.2. Gene Editing Market Snippet By Technology
2.1.3. Gene Editing Market Snippet By End-User
2.1.4. Gene Editing Market Snippet by Country
2.1.5. Gene Editing Market Snippet by Region
2.2. Competitive Insights
3. Gene Editing Key Market Trends
3.1. Gene Editing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Gene Editing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Gene Editing Market Opportunities
3.4. Gene Editing Market Future Trends
4. Gene Editing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Gene Editing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Gene Editing Market Landscape
6.1. Gene Editing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Gene Editing Market – By Application
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
7.1.2. Cell Line Engineering
7.1.3. Animal Genetic Engineering
7.1.4. Plant Genetic Engineering
7.1.5. Others
8. Gene Editing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. CRISPR/Cas9
8.1.3. Zinc Finger Nucleases (ZFNs)
8.1.4. TALENs
8.1.5. Others
9. Gene Editing Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
9.1.2. Biotech And Pharma Companies
9.1.3. Contract Research Organizations (CROs)
9.1.4. Research Institutes
10. Gene Editing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Gene Editing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Gene Editing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Gene Editing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Gene Editing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Gene Editing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Gene Editing Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Horizon Discovery Ltd.
11.2.2. Sangamo Therapeutics, Inc.
11.2.3. GenScript
11.2.4. Integrated DNA Technologies, Inc.
11.2.5. Precision Biosciences
11.2.6. Bearn Therapeutics
11.2.7. Thermo Fisher Scientific Inc.
11.2.8. Intellia Therapeutics, Inc.
11.2.9. CRISPR Therapeutics
11.2.10. Caribou Biosciences, Inc.
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

Choose License Type
assit assit

Tailor made solution just for you

80% of our clients seek made-to-order reports. how do you want us to tailor yours?
📧 Talk to Analyst

We have 24/7 dedicated support team.

Get in Touch

© 2025. All rights reserved: AnalystView Market Insights